Cell Therapy Market - Global Outlook and Forecast 2022-2028
Cell Therapy (also called cellular therapy, cell transplantation, or cytotherapy) is a therapy in which viable cells are injected, grafted or implanted into a patient in order to effectuate a medicinal effect, for example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity in the course of immunotherapy, or grafting stem cells to regenerate diseased tissues.
Global Cell Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cell Therapy market was valued at 103920 million in 2021 and is projected to reach US$ 243270 million by 2028, at a CAGR of 12.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Stem Cell Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cell Therapy include Gilead Sciences, Novartis, Osiris, Vericel Corporation, Vcanbio, Fujifilm Cellular Dynamics, JCR Pharmaceuticals, Beike Biotechnology and Golden Meditech and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
|Related Link: Click here to visit item owner's website (0 hit)|
|Target Prov.: All Provinces|
Target City : Navi Mumbai
Last Update : Feb 22, 2022 10:44 PM
Number of Views: 30
|Item Owner : vidhya|
Contact Phone: (None)
|Friendly reminder: Click here to read some tips.|